e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Special treatment options in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis
N. Eremeeva (Yekaterinburg, Russian Federation)
Source:
Annual Congress 2010 - Special treatment options in tuberculosis
Session:
Special treatment options in tuberculosis
Session type:
Thematic Poster Session
Number:
3132
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Eremeeva (Yekaterinburg, Russian Federation). Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3132
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis
Source: Eur Respir J 2015; 46: 444-455
Year: 2015
Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant
mycobacterium tuberculosis
in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Considerations upon the drug resistance spectrum of
Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 313s
Year: 2001
Clinical efficacy and safety of fluoroquinolone containing regimens in patients with
Mycobacterium avium
complex pulmonary disease
Source: Eur Respir J, 55 (4) 1901240; 10.1183/13993003.01240-2019
Year: 2020
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan
Source: International Congress 2019 – Drug-resistant tuberculosis
Year: 2019
Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
The effect of tobacco smoking on drug sensitivity and microbiological characteristics of
Mycobacterium tuberculosis
(MTB): clinical and experimental study
Source: Eur Respir J 2003; 22: Suppl. 45, 158s
Year: 2003
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Evaluation of treatment outcomes for multidrug-resistant tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Comparison of performance in two diagnostic methods for
M. tuberculosis
infection
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
The Glutoxim influence on minimum inhibitory concentration of isoniazid-resistant strains of Mycobacterium tuberculosis
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
Bedaquiline as a potential agent in the treatment of
Mycobacterium abscessus
infections
Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017
Year: 2017
Results of multicentral external quality assessment for
M. tuberculosis
drug susceptibility testing in Russia
Source: Eur Respir J 2005; 26: Suppl. 49, 646s
Year: 2005
Routine survey of
Mycobacterium tuberculosis
isolates reveals nosocomial transmission
Source: Eur Respir J, 55 (3) 1901888; 10.1183/13993003.01888-2019
Year: 2020
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
In vitro susceptibility testing of bedaquiline against mycobacteria avium-intracellulare complex
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept